These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 24846455

  • 21. TIOtropium Safety and Performance In Respimat® (TIOSPIRTM ): Analysis of Asian cohort of COPD patients.
    Zhong N, Moon HS, Lee KH, Mahayiddin AA, Boonsawat W, Isidro MG, Bai C, Mueller A, Metzdorf N, Anzueto A.
    Respirology; 2016 Nov; 21(8):1397-1403. PubMed ID: 27490162
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ten years of tiotropium: clinical impact and patient perspectives.
    Yohannes AM, Connolly MJ, Hanania NA.
    Int J Chron Obstruct Pulmon Dis; 2013 Nov; 8():117-25. PubMed ID: 23515335
    [Abstract] [Full Text] [Related]

  • 24. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR, ZuWallack RL.
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial.
    Wise RA, Calverley PM, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A.
    Int J Chron Obstruct Pulmon Dis; 2018 Aug; 13():605-616. PubMed ID: 29497289
    [Abstract] [Full Text] [Related]

  • 27. Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD.
    Hodder R, Pavia D, Lee A, Bateman E.
    Int J Chron Obstruct Pulmon Dis; 2011 Aug; 6():245-51. PubMed ID: 21814460
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies.
    Bateman E, Singh D, Smith D, Disse B, Towse L, Massey D, Blatchford J, Pavia D, Hodder R.
    Int J Chron Obstruct Pulmon Dis; 2010 Aug 09; 5():197-208. PubMed ID: 20714373
    [Abstract] [Full Text] [Related]

  • 31. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
    Verhamme KM, Afonso AS, van Noord C, Haag MD, Koudstaal PJ, Brusselle GG, Sturkenboom MC.
    Pulm Pharmacol Ther; 2012 Feb 09; 25(1):19-26. PubMed ID: 22051450
    [Abstract] [Full Text] [Related]

  • 32. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J, Zhou Z, Tang Y, Zhong N.
    Zhonghua Nei Ke Za Zhi; 2014 Dec 09; 53(12):964-8. PubMed ID: 25623564
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
    Rau-Berger H, Mitfessel H, Glaab T.
    Int J Chron Obstruct Pulmon Dis; 2010 Oct 10; 5():367-73. PubMed ID: 21103403
    [Abstract] [Full Text] [Related]

  • 38. Bronchodilator Effect of Tiotropium via Respimat®Administered with a Spacer in Patients with Chronic Obstructive Pulmonary Disease (COPD).
    Ogasawara T, Sakata J, Aoshima Y, Tanaka K, Yano T, Kasamatsu N.
    Intern Med; 2017 Sep 15; 56(18):2401-2406. PubMed ID: 28824055
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
    Schmiedl S, Fischer R, Ibanez L, Fortuny J, Thürmann P, Ballarin E, Ferrer P, Sabaté M, Rottenkolber D, Gerlach R, Tauscher M, Reynolds R, Hasford J, Rottenkolber M.
    Br J Clin Pharmacol; 2016 Feb 15; 81(2):379-88. PubMed ID: 26506314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.